The tumor suppressor microrna-1 exhibits restricted inhibition of proliferation of ovarian cancer cells

Anticancer Research

Volumn 36, Issue 7, 2016, Pages 3329-3334

  Stope, Matthias B ^a   Wiegank, Luise ^a   Weiss, Martin ^a   Diesing, Karoline ^a   Koensgen, Dominique ^a   Burchardt, Martin ^a   Zygmunt, Marek ^a   Mustea, Alexander ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

MicroRNA miR 1; Ovarian cancer; Proliferation; Tumor suppressor

Indexed keywords

MICRORNA 1; MICRORNA; MIRN1 MICRORNA, HUMAN;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL GROWTH; GENETIC TRANSFECTION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

CASE-CONTROL STUDIES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 84992126264     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sehouli J, Alvarez AM, Manouchehrpour S, Ghatage P, Szczylik C, Zimmermann A, Bauknecht T, Look KY and Oskay-Öezcelik G: A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer. Gynecol Oncol 124: 205-209, 2012.
2. Ayaz L, Cayan F, Balci S, Gorur A, Akbayir S, Yaroglu HY, Doruer Unal N and Tamer L: Circulating microRNA expression profiles in ovarian cancer. J Obstet Gynaecol 34: 620-624, 2014.
3. Banno K, Yanokura M, Iida M, Adachi M, Nakamura K, Nogami Y, Umene K, Masuda K, Kisu I, Nomura H, Kataoka F, Tominaga E and Aoki D: Application of microRNA in diagnosis and treatment of ovarian cancer. Biomed Res Int 2014: 232817, 2014.
4. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
5. Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187, 2006.
6. Baranwal S and Alahari SK: miRNA control of tumor cell invasion and metastasis. Int J Cancer 126: 1283-1290, 2010.
7. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M and Dinney C: miR-200 expression regulates epithelial-tomesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Cancer Res 15: 5060-5072, 2009.
8. Acunzo M, Romano G, Wernicke D and Croce CM: MicroRNA and cancer-A brief overview. Adv Biol Regul 57: 1-9, 2015.
9. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002.
10. Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie RP, Garcia-Barrio MT, Zhang J and Chen YE: MicroRNA-1 regulates smooth muscle cell differentiation by repressing KLF4. Stem Cells Dev 20: 205-210, 2010.
11. Chen J, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233, 2006.
12. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA and Goumans MJ: MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 30: 859-868, 2010.
13. Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang Z, Li J, Shi Z, Kilsdonk EP, Gui Y, Wang DZ and Zheng XL: Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 31: 368-375, 2011.
14. Chen J, Tao Y, Li J, Deng Z, Yan Z, Xiao X and Wang DZ: microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190: 867-879, 2010.
15. Stope MB, Stender C, Schubert T, Peters S, Weiss M, Ziegler P, Zimmermann U, Walther R and Burchardt M: Heat-shock protein HSPB1 attenuates microRNA miR-1 expression thereby restoring oncogenic pathways in prostate cancer cells. Anticancer Res 34: 3475-3480, 2014.
16. Liu Y, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P and Kelly K: MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumor genesis via Slug-independent mechanisms. Oncogene 32: 296-306, 2013.
17. Chen W, Leung C, Pan H, Hu L, Li S, Ho M and Tsai KW: Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 28: 1069-1076, 2012.
18. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto Y and Seki N: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2: 29-42, 2011.
19. Lu J, Zhao F, Peng Z, Zhang M, Lin S, Liang B, Zhang B, Liu X, Wang L, Li G, Tian WD, Peng Y, He ML and Li XP: EZH2 promotes angiogenesis through inhibition of miR-1/endothelin-1 axis in nasopharyngeal carcinoma. Oncotarget 5: 11319-11332, 2014.
20. Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M and Pierotti MA: miRNA profiling in colorectal cancer highlights miR-1 Involvement in METdependent proliferation. Mol Cancer Res 10: 504-515, 2012.
21. Xu L, Zhang Y, Wang H, Zhang G, Ding Y and Zhao L: Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway. J Transl Med 12: 244, 2014.
22. Karatas OF, Guzel E, Suer I, Ekici ID, Caskurlu T, Creighton CJ, Ittmann M and Ozen M: miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One 9: e98675, 2014.
23. Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M and Seki N: Tumor suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 106: 405-413, 2012.
24. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N and Nakagawa M: The functional significance of miR-1 and miR-133a in renal cell carcinoma. EJC 48: 827-836, 2012.
25. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa M: The tumorsuppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
26. Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, Tognon M, Picci P and Benassi MS: miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42: 667-675, 2012.
27. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y and Seki N: Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 39: 1099-1107, 2011.
28. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405, 2008.
29. Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, Comoglio PM, Columbano A and Giordano S: miR-1 down-regulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 18: 737-747, 2012.
30. Stope MB, Delogu S, Diesing K, Klinkmann G, Evert M, Koensgen D, Zygmunt M, Burchardt M and Mustea A: Expression pattern of the microRNA miR-1 in ovarian cancer cell lines and tumor tissue samples implies a loss of miR-1's tumor suppressor properties. RNA Dis 1: e348, 2014.
31. Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X and Liang S: Roles of microRNA on cancer cell metabolism. J Transl Med 10: 228, 2012.
32. Yamamoto N, Nishikawa R, Chiyomaru T, Goto Y, Fukumoto I, Usui H, Mitsuhashi A, Enokida H, Nakagawa M, Shozu M and Seki N: The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer, Int J Oncol 47: 325-334, 2015.
33. Huang D, Wang H, Liu R, Li H, Ge S, Bai M, Deng T, Yao G and Ba Y: miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. J Cell Biochem 115: 549-556, 2014.
34. Blade C, Baselga-Escudero L, Josepa Salvadó M and Arola-Arnal A: miRNAs, polyphenols, and chronic disease. Mol Nutr Food Res 57: 58-70, 2013.
35. Dumortier O, Hinault C and Van Obberghen E: MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metabolism 18: 313-324, 2013.
36. Asgari Y, Zabihinpour Z, Salehzadeh-Yazdi A, Schreiber F and Masoudi-Nejad A: Alterations in cancer cell metabolism: The Warburg effect and metabolic adaptation. Genomics 105: 275-281, 2015.
37. Cordes K and Srivastava D: MicroRNA Regulation of cardiovascular development. Circ Res 104: 724-732, 2009.
38. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ and Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.